Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials

Concerns have been raised regarding an increased risk of major adverse cardiovascular events (MACEs) (myocardial infarction, cerebrovascular accident or cardiovascular death) in patients treated with anti‐interleukin (IL)‐12/23 agents for moderate‐to‐severe psoriasis. We aimed to examine the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rungapiromnan, W., Yiu, Z.Z.N., Warren, R.B., Griffiths, C.E.M., Ashcroft, D.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412670/
https://www.ncbi.nlm.nih.gov/pubmed/27518205
http://dx.doi.org/10.1111/bjd.14964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412670/
https://www.ncbi.nlm.nih.gov/pubmed/27518205
http://dx.doi.org/10.1111/bjd.14964

Ejemplares similares